Workflow
Alcha(002160)
icon
Search documents
长春高新拟发行H股;杭州高新实控人拟变更丨公告精选
Group 1: Company Announcements - Changchun High-tech plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and international brand image [1] - Saisir reported June sales of 46,086 new energy vehicles, a year-on-year increase of 4.44%, with a total of 172,100 units sold in the first half of the year, down 14.35% year-on-year [1] - Hangzhou High-tech announced a change in controlling shareholder to Jirong Weiye, with stock resuming trading on July 2, 2025 [1] Group 2: Financial Performance - Guomai Technology expects a net profit of 125 million to 156 million yuan for the first half of 2025, a year-on-year increase of 60.52% to 100.33% [2] - Kid King anticipates a net profit of 120 million to 160 million yuan for the first half of 2025, representing a year-on-year growth of 50% to 100% [2] - Mould Technology received a project from a well-known North American electric vehicle company, with expected total sales of 1.236 billion yuan over five years [3] Group 3: Regulatory and Compliance - *ST Yuancheng is under investigation by the China Securities Regulatory Commission for suspected false disclosures in financial reports [4] - The company received a notice of investigation on July 1, 2025, which may lead to significant penalties and potential delisting [4] Group 4: Market Activity - Changcheng Military Industry's stock has experienced significant volatility, with a cumulative price deviation exceeding 20% over three trading days, indicating potential irrational speculation [5] - Anglikang has only one innovative drug project, ALK-N001, currently in Phase I clinical trials, highlighting the long and uncertain nature of drug development [6] Group 5: Sales and Contracts - Beiqi Blue Valley's subsidiary reported a 139.73% year-on-year increase in sales for the first half of the year [7] - Dong'an Power's engine sales in June increased by 82.79% year-on-year [7] - Pudong Construction's subsidiary won multiple major projects with a total bid amount of 1.964 billion yuan [7]
7月1日晚间重要公告一览
Xi Niu Cai Jing· 2025-07-01 10:29
Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]
常铝股份(002160) - 关于下属子公司签订日常经营合同的公告
2025-07-01 08:00
本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 特别提示: 证券代码:002160 证券简称:常铝股份 公告编号:2025-044 江苏常铝铝业集团股份有限公司 关于下属子公司签订日常经营合同的公告 合同在未来履行过程中可能存在违约风险;如遇政策、市场环境重大变化等 不可抗力因素的影响,可能会导致合同存在无法全部履行或终止履行的风险。 一、合同签署概况 近日,江苏常铝铝业集团股份有限公司(以下简称"公司")全资子公司上 海朗脉洁净技术股份有限公司(以下简称"上海朗脉")与康乐卫士(昆明)生 物技术有限公司(以下简称"康乐卫士")签订《重组疫苗临床及产业化基地厂 房定制化建设项目(一期)5#楼3层HPV九价原液车间项目洁净装修、机电安装及 设备供货总承包合同》,由上海朗脉负责康乐卫士重组疫苗临床及产业化基地厂 房定制化建设项目(一期)5#楼3层HPV九价原液车间项目洁净装修、机电安装及 设备供货总承包施工及设备供货。 根据有关规则及《公司章程》等的规定,该合同的签订无需经公司董事会以 及股东大会审议。本次交易不构成关联交易和《上市公司重大资产重组管理办法》 所规 ...
常铝股份:子公司签订1.65亿元合同
news flash· 2025-07-01 07:49
Group 1 - The core point of the article is that Chang Aluminum Co., Ltd. announced a contract worth RMB 165 million with Kang Le Wei Shi (Kunming) Biotechnology Co., Ltd. for the construction of a cleanroom facility for HPV vaccine production [1] - The contract represents 18.11% of Shanghai Langmai's audited main business revenue for the year 2024, indicating a significant contribution to the company's financials [1] - The signing of this contract is expected to have a positive impact on the company's medical clean health business segment [1]
常铝股份(002160) - 关于全资子公司为孙公司提供担保的进展公告
2025-06-18 09:46
证券代码:002160 证券简称:常铝股份 公告编号:2025-043 江苏常铝铝业集团股份有限公司 关于全资子公司为孙公司提供担保的进展公告 本公司及董事会全体成员保证公告内容真实、准确、完整,没有虚假记载、误 导性陈述或者重大遗漏。 一、担保情况概述 二、担保进展情况 (一)上海朗脉下属控股子公司常州朗脉洁净技术有限公司(以下简称"常州 朗脉")因其经营需要,向中国民生银行股份有限公司上海分行(以下简称"民生 银行")申请人民币1000万元综合授信额度,期限为壹年。 (二)为保证上述融资事项的顺利进行,上海朗脉拟与民生银行签订担保合同, 为常州朗脉向民生银行申请的银行融资事项提供连带责任担保,担保额度为1000万 元。 近日,上海朗脉已就上述担保事项履行了其内部审议程序。 根据《深圳证券交易所股票上市规则》等的相关规定,上述担保事项无需再次 提交公司董事会或股东大会审议。 三、被担保人基本情况 江苏常铝铝业集团股份有限公司(以下简称"公司")于2025年03月14日召开 的第七届董事会第十九次(临时)会议、2025年03月31日召开的2025年第一次临时 股东大会审议并通过了《关于2025年度担保额度预计 ...
常铝股份: 关于全资子公司为孙公司提供担保的进展公告
Zheng Quan Zhi Xing· 2025-06-18 08:20
Summary of Key Points Core Viewpoint - Jiangsu Chang Aluminum Industry Group Co., Ltd. has approved a guarantee plan for its subsidiary Shanghai Langmai Clean Technology Co., Ltd. to facilitate financing needs, with a total guarantee amount of up to 180 million yuan [1][4]. Guarantee Situation Overview - The company held a board meeting on March 14, 2025, and a shareholders' meeting on March 31, 2025, to approve the guarantee plan for the fiscal year 2025 [1]. - The maximum guarantee amount for Shanghai Langmai is set at 180 million yuan, with specific conditions based on the asset-liability ratio of the subsidiaries involved [1]. Guarantee Progress - Shanghai Langmai's subsidiary, Changzhou Langmai Clean Technology Co., Ltd., has applied for a comprehensive credit limit of 10 million yuan from China Minsheng Bank for one year [2]. - To ensure the financing process, Shanghai Langmai plans to sign a guarantee contract with Minsheng Bank, providing joint liability guarantee for the 10 million yuan financing [2]. Basic Information of the Guaranteed Party - Changzhou Langmai Clean Technology Co., Ltd. was established on November 8, 2011, with a registered capital of 120 million yuan [2]. - The company operates in the clean technology sector, including technology development, equipment manufacturing, and project management [2]. Financial Data - As of the end of 2024, total assets were 221.96 million yuan, and total liabilities were 113.90 million yuan, resulting in net assets of 108.05 million yuan [3]. - For the first quarter of 2025, the company reported a revenue of 2.29 million yuan and a net loss of 3.69 million yuan [3]. Board of Directors' Opinion - The board believes that mutual guarantees between Shanghai Langmai and its subsidiaries will help meet financing needs and that the overall guarantee risk is controllable [4]. Cumulative External Guarantee Amount - As of the announcement date, the total approved guarantee amount provided by the company to its subsidiaries is 14.89% of net assets, with no overdue guarantees reported [4].
常铝股份: 关于对子公司提供担保的进展公告
Zheng Quan Zhi Xing· 2025-06-10 08:14
Group 1 - The company approved a guarantee limit of up to 160 million RMB for 2025, with 80 million RMB specifically for Shanghai Langmai Clean Technology Co., Ltd [1] - On June 10, 2025, the company signed a maximum joint liability guarantee with Jiangsu Bank for a total amount of 6 million RMB to support Shanghai Langmai's financing [2] - The company holds a 99.98% stake in Shanghai Langmai, with an additional indirect holding of 0.02% through its subsidiary [4][7] Group 2 - Shanghai Langmai's total assets increased from 1.709 billion RMB at the end of 2024 to 1.816 billion RMB by the end of March 2025, while total liabilities rose from 1.106 billion RMB to 1.220 billion RMB in the same period [6] - The company's net profit for the first quarter of 2025 was reported at -75.79 million RMB, indicating a loss compared to a profit of 29.87 million RMB in the same period of the previous year [6] - The company has no overdue guarantees and has not provided guarantees for entities outside the consolidated financial statements [5][6]
常铝股份(002160) - 关于对子公司提供担保的进展公告
2025-06-10 08:00
本公司及董事会全体成员保证信息披露的内容真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 证券代码:002160 证券简称:常铝股份 公告编号:2025-042 江苏常铝铝业集团股份有限公司 关于对子公司提供担保的进展公告 三、被担保方基本情况 1、工商基本情况 名称:上海朗脉洁净技术股份有限公司 一、担保情况概述 江苏常铝铝业集团股份有限公司(以下简称"公司")于2025年03月14日召 开的第七届董事会第十九次(临时)会议、2025年03月31日召开的2025年第一次 临时股东大会审议并通过了《关于2025年度担保额度预计的议案》,同意公司2025 年度向各子公司提供总额不超过160,000万元担保额度,其中向上海朗脉洁净技 术股份有限公司(以下简称"上海朗脉")提供担保的总额度不超过80,000万元, 期限自股东大会审议通过之日起至下年度审议对外担保额度预计的股东大会审 议通过之日止,任一时点的担保余额不得超过股东大会审议通过的担保额度。具 体 内 容详 见于 2025年 03 月 15 日在 指定媒 体 《证 券时 报》及 巨 潮资 讯 网 (www.cninfo.com.cn)刊登的《关于2 ...
A股午评 | 三大指数小幅下跌 市场热点轮动较快 化工、固态电池等板块走强
智通财经网· 2025-06-06 03:45
6月6日,A股早盘窄幅震荡,超2900只个股下跌,半日成交额7467亿,较上个交易日放量324亿。截至 收盘,沪指跌0.06%,深成指跌0.18%,创业板指跌0.48%。 消息面上,因特朗普与马斯克关系恶化,隔夜美股高开低走,三大指数集体收跌,大型科技股多数下 跌,特斯拉暴跌逾14%市值跌破万亿。 盘面上,市场热点轮动较快,煤炭、银行等高股息风格活跃,大有能源涨停;有色金属板块走强,白银 方向领涨,湖南白银等涨停;化工板块走高,氟化工方向领涨,三美股份、巨化股份双双创历史新高; 固态电池概念拉升,海辰药业20%涨停;存储芯片概念异动,好上好涨停;此外,军工、建筑装饰等板 块盘中均轮动表现。下跌方面,IP经济、宠物经济等新消费概念走低,足球概念回调,游戏、汽车等板 块跌幅居前。 展望后市,中国银河认为,短期内,市场或仍维持震荡格局,关注外部关税的变化与国内政策的落地节 奏。 热门板块 1、有色金属板块走强 有色金属板块走强,白银方向领涨,白银有色、湖南白银、厦门信达等涨停,兴业银锡、盛达资源等跟 涨。 点评:消息面上,周四现货白银一度暴涨4.5%,触及每盎司36美元整数关口的上方,创下2012年2月以 来最高水 ...
常铝股份(002160) - 关于董事会、监事会完成换届选举及聘任高级管理人员、证券事务代表、内审负责人的公告
2025-05-27 08:30
证券代码:002160 证券简称:常铝股份 公告编号:2025-041 江苏常铝铝业集团股份有限公司 关于董事会、监事会完成换届选举及聘任高级管理人员、 证券事务代表、内审负责人的公告 本公司及董事会、监事会全体成员保证信息披露的内容真实、准确和完整, 没有虚假记载、误导性陈述或重大遗漏。 江苏常铝铝业集团股份有限公司(以下简称"公司")于 2025 年 5 月 26 日召开了公司 2024 年度股东大会,选举产生了第八届董事会非独立董事 7 名、 独立董事 4 名,共同组成公司新一届董事会;选举产生了第八届监事会非职工代 表监事 2 名,并与经公司职工代表大会选举产生的 1 名职工代表监事共同组成公 司新一届监事会。 同日,公司召开第八届董事会第一次会议及第八届监事会第一次会议,其 中:董事会选举产生了公司第八届董事会董事长、副董事长、董事会各专门委员 会委员,聘任了公司高级管理人员、证券事务代表和内部审计负责人;监事会选 举产生了公司第八届监事会主席。现将相关事项公告如下: 一、第八届董事会组成情况 (一)董事会组成情况 公司第八届董事会由 11 名董事组成,其中非独立董事 7 名,独立董事 4 名, 具 ...